{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-22-005358","form_type":"8-K","ticker":"JYNT","cik":"0001612630","company_name":"JOINT Corp","filed_at":"2022-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.360816+00:00","generated_at":"2026-06-24T04:10:08.956672+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"The Joint Corp Q2 revenue rises 24% to $25.1M, net income plunges to $345k from $2.7M","bullets":["Revenue $25.1M (+24% YoY); net income $345k ($0.02 EPS) vs $2.7M ($0.18) prior year.","Adjusted EBITDA $2.6M, down from $3.8M; operating income $473k vs $2.0M.","System-wide sales $106M (+21%); system-wide comp sales +8%; total clinics 769 (+33 net).","Cash $9.4M at June 30, down from $19.5M at Dec 31 due to clinic acquisitions and greenfields.","FY 2022 guidance reaffirmed: revenue $98-102M, Adj EBITDA $12-14M, franchised openings 110-130."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-22-005358","json":"https://secwatch.observer/filing/0001171843-22-005358.json","markdown":"https://secwatch.observer/filing/0001171843-22-005358.md","text":"https://secwatch.observer/filing/0001171843-22-005358.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1612630/000117184322005358/0001171843-22-005358-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1612630/000117184322005358/f8k_080422.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T04:10:08.956672+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}